SpringerLink
Log in

Careers and Opportunities in Medical Biotechnology

  • Chapter
  • First Online:
Fundamentals and Advances in Medical Biotechnology

  • 805 Accesses

Abstract

This chapter presents a general overview of biotechnology as a science and as an industry of immense economic value. The many industrial applications of biotechnology have been enumerated and then we have gone to discuss the dynamic sector of medical and pharmaceutical biotechnology in some detail. We have discussed the economics of pharmaceutical biotechnology particularly focusing on the reasons why the products and services it creates have a price tag so high that they become almost inaccessible for so many who need those. Additionally, an attempt has been made to introduce the relatively much newer concepts of bio-industry and bio-economy. We have further briefly presented information about the top 5 global biotechnology companies, incidentally all happen to belong to the medical and pharmaceutical biotechnology sector, and have finally discussed about being an entrepreneur in the world of biotechnology and what that entails.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Sasson A (2005) Medical biotechnology: achievements, prospects and perceptions. United Nations University Press, New York, pp 1–16

    Google Scholar 

  2. Dupont-Inglis J, Borg A (2018) Destination bioeconomy—the path towards a smarter, more sustainable future. N Biotechnol 40(Pt A):140–143

    Article  CAS  PubMed  Google Scholar 

  3. D'Amato D, Bartkowski B, Droste N (2020) Reviewing the interface of bioeconomy and ecosystem service research. Ambio 49(12):1878–1896

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lokko Y, Heijde M, Schebesta K, Scholtes P, Van Montagu M, Giacca M (2018) Biotechnology and the bioeconomy—towards inclusive and sustainable industrial development. N Biotechnol 40(Pt A):5–10

    Article  CAS  PubMed  Google Scholar 

  5. Verma AS, Agrahari S, Rastogi S, Singh A (2011) Biotechnology in the realm of history. J Pharm Bioallied Sci 3(3):321–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Evans G, Austin F (2010) Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions. Sci Transl Med 2(63):63mr3

    Article  PubMed  Google Scholar 

  7. Aguilar A, Bochereau L, Matthiessen L (2010) Biotechnology as the engine for the knowledge-based bio-economy. Biotechnol Genet Eng Rev 26:371–388

    Article  PubMed  Google Scholar 

  8. Lazebnik Y, Parris GE (2015) Comment on: Guidelines for the use of cell lines in biomedical research: human-to-human cancer transmission as a laboratory safety concern. Br J Cancer 112(12):1976–1977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bain DL, Brenowitz M, Roberts CJ (2016) An opportunity for industry–academia partnership: training the next generation of industrial researchers in characterizing higher order protein structure. J Pharm Sci 105(12):3483–3486

    Article  CAS  PubMed  Google Scholar 

  10. Khan S, Ullah MW, Siddique R, Nabi G, Manan S, Yousaf M et al (2016) Role of recombinant DNA technology to improve life. Int J Genom 2016:2405954

    Google Scholar 

  11. Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R (2021) Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A 118(21):e2105968118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Di L, Fu Y, Sun Y, Li J, Liu L, Yao J et al (2020) RNA sequencing by direct tagmentation of RNA/DNA hybrids. Proc Natl Acad Sci U S A 117(6):2886–2893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mallela K (2010) Pharmaceutical biotechnology: concepts and applications. Hum Genomics 4(3):218–219

    Article  PubMed Central  Google Scholar 

  14. Ledford H (2015) Biotech boot camp. Nature 519(7544):402–405

    Article  CAS  PubMed  Google Scholar 

  15. Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E et al (2021) Global map** of cancers: The Cancer Genome Atlas and beyond. Mol Oncol 15(11):2823–2840

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chial H (2008) DNA sequencing technologies key to the human genome project. Nat Educ 1(1):219

    Google Scholar 

  17. Gurwitz D, Bregman-Eschet Y (2009) Personal genomics services: whose genomes? Eur J Hum Genet 17(7):883–889

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kotnik T, Frey W, Sack M, Meglic SH, Peterka M, Miklavcic D (2015) Electroporation-based applications in biotechnology. Trends Biotechnol 33(8):480–488

    Article  CAS  PubMed  Google Scholar 

  19. Flier JS (2019) Academia and industry: allocating credit for discovery and development of new therapies. J Clin Investig 129(6):2172–2174

    Article  PubMed  PubMed Central  Google Scholar 

  20. Maurya RK, Patel AR, Sarkar P, Singh H, Tyagi H (2017) Biomass, its potential and applications. In: Biorefining of biomass to biofuels. Springer, Cham, pp 25–52

    Google Scholar 

  21. Ruiz Sierra A, Zika E, Lange L, Ruiz de Azua PL, Canalis A, Mallorquin Esteban P et al (2021) The bio-based industries joint undertaking: a high impact initiative that is transforming the bio-based industries in Europe. N Biotechnol 60:105–112

    Article  CAS  PubMed  Google Scholar 

  22. Kircher M (2021) Bioeconomy: present status and future needs of industrial value chains. N Biotechnol 60:96–104

    Article  CAS  PubMed  Google Scholar 

  23. Aguilar A, Twardowski T, Wohlgemuth R (2019) Bioeconomy for sustainable development. Biotechnol J 14(8):e1800638

    Article  PubMed  CAS  Google Scholar 

  24. Guo M, Song W (2019) The growing U.S. bioeconomy: drivers, development and constraints. N Biotechnol 49:48–57

    Article  CAS  PubMed  Google Scholar 

  25. Dash A, Kundu D, Das M, Bose D, Adak S, Banerjee R (2016) Food biotechnology: a step towards improving nutritional quality of food for Asian countries. Recent Pat Biotechnol 10(1):43–57

    Article  CAS  PubMed  Google Scholar 

  26. Rischer H, Szilvay GR, Oksman-Caldentey KM (2020) Cellular agriculture—industrial biotechnology for food and materials. Curr Opin Biotechnol 61:128–134

    Article  CAS  PubMed  Google Scholar 

  27. Schurrle K (2020) History, current state, and emerging applications of industrial biotechnology. Adv Biochem Eng Biotechnol 173:13–51

    PubMed  Google Scholar 

  28. Issa I, Delbruck S, Hamm U (2019) Bioeconomy from experts’ perspectives—results of a global expert survey. PLoS One 14(5):e0215917

    Article  PubMed  PubMed Central  Google Scholar 

  29. Clarke L, Kitney R (2020) Develo** synthetic biology for industrial biotechnology applications. Biochem Soc Trans 48(1):113–122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Makurvet FD (2021) Biologics vs. small molecules: drug costs and patient access. Med Drug Discov 9:1–8

    CAS  Google Scholar 

  31. Blackstone EA, Joseph PF (2013) The economics of biosimilars. Am Health Drug Benef 6(8):469–478

    Google Scholar 

  32. Ngo HX, Garneau-Tsodikova S (2018) What are the drugs of the future? Medchemcomm 9(5):757–758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Vincent RS (2020) The high cost of prescription drugs: causes and solutions. Blood Cancer J 10(6):71

    Article  Google Scholar 

  34. Wilson AW, Neumann PJ (2012) The cost-effectiveness of biopharmaceuticals: a look at the evidence. MAbs 4(2):281–288

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rome BN, Lee CC, Kesselheim AS (2021) Market exclusivity length for drugs with new generic or biosimilar competition, 2012–2018. Clin Pharmacol Ther 109(2):367–371

    Article  PubMed  Google Scholar 

  36. Yang EJ, Galan E, Thombley R, Lin A, Seo J, Tseng CW et al (2020) Changes in drug list prices and amounts paid by patients and insurers. JAMA Netw Open 3(12):e2028510

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nolla JM, Martin E, Llamas P, Manero J, de la Rodriguez Serna A, Fernandez-Miera MF et al (2017) An estimate of the cost of administering intravenous biological agents in Spanish day hospitals. Ther Clin Risk Manag 13:325–334

    Article  PubMed  PubMed Central  Google Scholar 

  38. Martin DK, Vicente O, Beccari T, Kellermayer M, Koller M, Lal R, Marks RS, Marova I, Mechler A, Tapaloaga D, Žnidaršič-Plazl P (2021) A brief overview of global biotechnology. Biotechnol Biotechnol Equip 35:S5–S14

    Article  Google Scholar 

  39. Timmis K, de Lorenzo V, Verstraete W, Ramos JL, Danchin A, Brussow H et al (2017) The contribution of microbial biotechnology to economic growth and employment creation. J Microbial Biotechnol 10(5):1137–1144

    Article  Google Scholar 

  40. Abong AE, Bosley K, Casebourn C, Chan P, Chen J, Chen M et al (2021) Voices of biotech leaders. Nat Biotechnol 39(6):654–660

    Article  CAS  Google Scholar 

  41. Ledley FD, McCoy SS, Vaughan G, Cleary EG (2020) Profitability of large pharmaceutical companies compared with other large public companies. JAMA 323(9):834–843

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tay-Teo K, Ilbawi A, Hill SR (2019) Comparison of sales income and research and development costs for FDA-approved cancer drugs sold by originator drug companies. JAMA Netw Open 2(1):e186875

    Article  PubMed  PubMed Central  Google Scholar 

  43. McKenzie H (2021) Q1 2021: A look at biopharma’s top 25 companies by market cap. BioSpacecom, Urbandale

    Google Scholar 

  44. Johnson & Johnson and subsidiaries, condensed consolidated statement of earnings. 2021

    Google Scholar 

  45. Fortune 500 list of corporations in the United States sorted in descending order of revenues ($M). 2021

    Google Scholar 

  46. F. Hoffmann-La Roche Ltd, Finance Report 2020. 2021

    Google Scholar 

  47. Ovartis AG (2021) Condensed Financial Report—Supplementary Data, Fourth Quarter and Full Year 2020

    Google Scholar 

  48. finance.yahoo.com (Searched for “NVS”)

    Google Scholar 

  49. Pfizer, Inc. (PFE) stock forecast and price target

    Google Scholar 

  50. Pfizer Inc., Form 10-K, Annual Report Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020

    Google Scholar 

  51. Haqqi T (2020) 5 Largest biotech companies in the world

    Google Scholar 

  52. Ball P (2021) The lightning-fast quest for COVID vaccines: and what it means for other diseases. Nature 589(7840):16–18

    Article  CAS  PubMed  Google Scholar 

  53. COVID research: a year of scientific milestones. Nature 2021 May 5. https://doi.org/10.1038/d41586-020-00502-w

  54. Weiland N, Grady D, Sanger D (2020) Pfizer gets 1.95 billion to produce coronavirus vaccine by years end. The New York Times, July 22 (https://www.nytimes.com/2020/07/22/us/politics/pfizer-coronavirus-vaccine.html)

  55. Reuters, Erman M, Mishra M (2021). U.S. drugmaker Merck sees bigger hit to full-year sales from pandemic. reuters.com, April 29 (https://www.reuters.com/business/healthcare-pharmaceuticals/merck-quarterlyprofit-falls-covid-19-hit-2021-04-29/)

  56. Amanpour S (2021) The rapid development and early success of Covid 19 vaccines have raised hopes for accelerating the cancer treatment mechanism. Arch Razi Inst 76(1):1–6

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Ku MS (2015) Recent trends in specialty pharma business model. J Food Drug Anal 23(4):595–608

    Article  PubMed  Google Scholar 

  58. Schuhmacher A, Gassmann O, McCracken N, Hinder M (2018) Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making? J Transl Med 16(1):119

    Article  PubMed  PubMed Central  Google Scholar 

  59. Fortner A, Schumacher D (2021) First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization. Discoveries (Craiova) 9(1):e122

    Article  Google Scholar 

  60. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC (2021) COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci 25(3):1663–1669

    CAS  PubMed  Google Scholar 

  61. Yetisen AK, Volpatti LR, Coskun AF, Cho S, Kamrani E, Butt H et al (2015) Entrepreneurship. Lab Chip 15(18):3638–3660

    Article  CAS  PubMed  Google Scholar 

  62. Froshauer S (2017) Careers at biotech start-ups and in entrepreneurship. Cold Spring Harb Perspect Biol 9(11):a032938

    Article  PubMed  PubMed Central  Google Scholar 

  63. Anand P, Stahel VP (2021) Review the safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 15(1):20

    Article  PubMed  PubMed Central  Google Scholar 

  64. Jackson RD, Gabriel S, Pariser A, Feig P (2010) Training the translational scientist. Sci Transl Med 2(63):63mr2

    Article  PubMed  Google Scholar 

  65. Chase J (2019) Innovation leadership in drug development. BioProcess International, Vienna

    Google Scholar 

  66. Ganem D (2018) Physician–scientist careers in the biotechnology and pharmaceutical industries. J Infect Dis 218(suppl_1):S20–SS4

    Article  PubMed  Google Scholar 

  67. Gross S, Sohl CD (2021) Readying students for careers in industry: a guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions. Biochem Mol Biol Educ 49(3):407–415

    Article  CAS  PubMed  Google Scholar 

  68. Miron-Shatz T, Shatz I, Becker S, Patel J, Eysenbach G (2014) Promoting business and entrepreneurial awareness in health care professionals: lessons from venture capital panels at medicine 2.0 conferences. J Med Internet Res 16(8):e184

    Article  PubMed  PubMed Central  Google Scholar 

  69. Festel G (2020) Economic aspects of industrial biotechnology. Adv Biochem Eng Biotechnol 173:53–74

    CAS  PubMed  Google Scholar 

  70. Madhavan G, Oakley B, Kun LG (2009) Career development in bioengineering and biotechnology. Series in biomedical engineering, vol 536. Springer, New York

    Google Scholar 

  71. Tan ECD, Lamers P (2021) Circular bioeconomy concepts—a perspective. Front Sustain 2:1–8

    Article  Google Scholar 

  72. Barañano L, Garbisu N, Alkorta I, Araujo A, Garbisu C (2021) Contextualization of the bioeconomy concept through its links with related concepts and the challenges facing humanity. Sustainability 13:1–18

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Formulation Scientist, New Delhi, India

    Ashish Sawhney

  2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia

    Mohd Imran

  3. Department of Zoology, Miranda House, University of Delhi, New Delhi, Delhi, India

    Saba Zulfiquar

  4. Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL, USA

    Mohammad Tauseef

Authors
  1. Ashish Sawhney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohd Imran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saba Zulfiquar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Tauseef
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA

    Mumtaz Anwar

  2. Department of Biotechnology, Wachemo University, Hosaena, Ethiopia

    Riyaz Ahmad Rather

  3. Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA

    Zeenat Farooq

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sawhney, A., Imran, M., Zulfiquar, S., Tauseef, M. (2022). Careers and Opportunities in Medical Biotechnology. In: Anwar, M., Ahmad Rather, R., Farooq, Z. (eds) Fundamentals and Advances in Medical Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-030-98554-7_15

Download citation

Publish with us

Policies and ethics

Search

Navigation